rs2127958
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005406.3(ROCK1):c.94-3036G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.454 in 151,864 control chromosomes in the GnomAD database, including 17,159 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.45 ( 17159 hom., cov: 31)
Consequence
ROCK1
NM_005406.3 intron
NM_005406.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.153
Publications
5 publications found
Genes affected
ROCK1 (HGNC:10251): (Rho associated coiled-coil containing protein kinase 1) This gene encodes a protein serine/threonine kinase that is activated when bound to the GTP-bound form of Rho. The small GTPase Rho regulates formation of focal adhesions and stress fibers of fibroblasts, as well as adhesion and aggregation of platelets and lymphocytes by shuttling between the inactive GDP-bound form and the active GTP-bound form. Rho is also essential in cytokinesis and plays a role in transcriptional activation by serum response factor. This protein, a downstream effector of Rho, phosphorylates and activates LIM kinase, which in turn, phosphorylates cofilin, inhibiting its actin-depolymerizing activity. A pseudogene, related to this gene, is also located on chromosome 18. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.562 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ROCK1 | NM_005406.3 | c.94-3036G>A | intron_variant | Intron 1 of 32 | ENST00000399799.3 | NP_005397.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.454 AC: 68885AN: 151746Hom.: 17165 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
68885
AN:
151746
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.454 AC: 68881AN: 151864Hom.: 17159 Cov.: 31 AF XY: 0.450 AC XY: 33395AN XY: 74198 show subpopulations
GnomAD4 genome
AF:
AC:
68881
AN:
151864
Hom.:
Cov.:
31
AF XY:
AC XY:
33395
AN XY:
74198
show subpopulations
African (AFR)
AF:
AC:
9784
AN:
41428
American (AMR)
AF:
AC:
6418
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
AC:
1952
AN:
3468
East Asian (EAS)
AF:
AC:
2798
AN:
5168
South Asian (SAS)
AF:
AC:
2269
AN:
4810
European-Finnish (FIN)
AF:
AC:
5455
AN:
10516
Middle Eastern (MID)
AF:
AC:
100
AN:
294
European-Non Finnish (NFE)
AF:
AC:
38457
AN:
67902
Other (OTH)
AF:
AC:
989
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1778
3556
5334
7112
8890
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
646
1292
1938
2584
3230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1459
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.